Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

September 30, 2004

Conditions
Sedation
Interventions
DRUG

midazolam

DRUG

lorazepam

DRUG

fentanyl

DRUG

morphine

DRUG

remifentanil

DRUG

propofol

Trial Locations (15)

5211 RW

GSK Investigational Site, 's-Hertogenbosch

1815 JD

GSK Investigational Site, Alkmaar

1081 HV

GSK Investigational Site, Amsterdam

7334 DZ

GSK Investigational Site, Apeldoorn

3318 AT

GSK Investigational Site, Dordrecht

6716 RP

GSK Investigational Site, Ede

5623 EJ

GSK Investigational Site, Eindhoven

2035 RC

GSK Investigational Site, Haarlem

5707 HA

GSK Investigational Site, Helmond

7555 DL

GSK Investigational Site, Hengelo

3015 GJ

GSK Investigational Site, Rotterdam

2512 VA

GSK Investigational Site, The Hague

4002 WP

GSK Investigational Site, Tiel

5912 BL

GSK Investigational Site, Venlo

8011 JW

GSK Investigational Site, Zwolle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00158873 - Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects | Biotech Hunter | Biotech Hunter